there were several congressional then gs with the administrator browner trying to explain to the committees in which e house and senate studies she used and which studies she didn't use in making her decision. the agency had upfront stated which were the pivotal studies and they made the information available to those studies. those a lot of controversies in the 1990's would have gone away. let me ask -- we're starting to run short on time. i have another question that in the weeds from maria of inside e.p.a. and i will read that to you before we to any wrap-up. i do have one or two other questions for you. maria at inside e.p.a. could the administrator address affect the cy will taska program? with a limited number of studies based on the valuations of existing chemicals as well as .b.i. issues, which we discussed, and releasing studies for several others. how will the e.p.a. ensure this doesn't exacerbate those forward?ing studies in very small numbers. sure.eeler: i don't think it will exacerbate that problem at all. in fact, it should help clear up some of the decisions under the new ta